Cargando…
Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients
OBJECTIVES: Distinction between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) based on clinical symptoms is often difficult. In this study we assessed the performance of the fully-automated calprotectin immunoassay from DiaSorin in IBD diagnosis and follow-up and compared it to...
Autores principales: | Vicente-Steijn, R., Jansen, J.M., Bisheshar, R., Haagen, I.-A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327250/ https://www.ncbi.nlm.nih.gov/pubmed/32637525 http://dx.doi.org/10.1016/j.plabm.2020.e00175 |
Ejemplares similares
-
Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples
por: Macias‐Muñoz, Laura, et al.
Publicado: (2022) -
New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method
por: Castiglione, Vincent, et al.
Publicado: (2022) -
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2021) -
Systematic Review of Diagnostic Accuracy of DiaSorin Liaison SARS-CoV-2 Antigen Immunoassay
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
Analytical Performance of Quantitative DiaSorin Liaison SARS-COV-2 Antigen Test for the Asymptomatic Population
por: Fernández-Rivas, Gema, et al.
Publicado: (2022)